Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00577915 · ClinicalTrials.gov registry record · NA
Breast MRI Spectroscopy
A NA study of Suspicion of, or Known Breast Cancer, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 150
- Enrollment target
- 1
- Study location
NCT00577915 is a NA study of Suspicion of, or Known Breast Cancer that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 150 participants. The trial reports 1 study location across 1 state.
The verdict
NCT00577915, a NA study of Suspicion of, or Known Breast Cancer, has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to provide physicians with additional information not available with standard imaging methods for breast disease. As part of the MRI examination ordered by your physician, a new method of analyzing the images or pictures will be used. This new method is called spectroscopy and is used routinely on other parts of the body such as the prostate and brain. Pictures produced with this sequence may look slightly different than the regular MRI pictures. Using spectroscopy data, it may be possible to distinguish benign conditions of the breast from malignant tumors and provide more precise information than can be obtained with regular MRI.
Conditions Studied
Interventions
- OTHER Radiology/MRI scan
Study Locations (1)
New York
- Memorial Sloan Kettering Cancer Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2003-05 |
| Est. Completion | 2016-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00577915
The ClinicalTrials.gov registry entry for NCT00577915 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Suspicion of, or Known Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which Radiology/MRI scan is the first listed.
NCT00577915 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT00577915 about?
NCT00577915 is a clinical study titled "Breast MRI Spectroscopy". The purpose of this study is to provide physicians with additional information not available with standard imaging methods for breast disease. As part of the MRI examination ordered by your physician, a new method of analyzing the images or pictures will be used. This new method is called spectrosc...
What is the current status of trial NCT00577915?
This trial is currently completed. It is a NA study. The enrollment target is 150 participants. The study started on 2003-05. Estimated completion is 2016-06.
What conditions does trial NCT00577915 study?
This clinical trial studies the following conditions: Suspicion of, or Known Breast Cancer.
What interventions are being tested in trial NCT00577915?
The interventions under investigation include: Radiology/MRI scan (OTHER).
Who is sponsoring clinical trial NCT00577915?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00577915 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.